Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06180837 · ClinicalTrials.gov registry record · NA

Effect of Sleep Extension on Ceramides in People with Overweight and Obesity

A NA study of Type 2 Diabetes and Sleep, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06180837 is a NA study of Type 2 Diabetes and Sleep that is actively recruiting participants, run by University of Utah. The registered enrollment target is 70 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06180837, a NA study of Type 2 Diabetes and Sleep, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The overall goal is to determine how a sleep extension intervention (increasing time in bed) in individuals who maintain less than 6.5 hours sleep per night affects their plasma ceramides and insulin sensitivity. Participants will undergo a randomized controlled trial, with sleep extension (intervention) and healthy lifestyle (control) groups. The sleep extension is designed to increase participant's time in bed by 2 hours per night. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).

Interventions

  • BEHAVIORAL Sleep Extension Intervention

Study Locations (1)

Utah

  • College of Health Research Complex--University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-02-12
Est. Completion 2028-01
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT06180837

The ClinicalTrials.gov registry entry for NCT06180837 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (94% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Sleep Extension Intervention is the first listed.

NCT06180837 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT06180837 about?

NCT06180837 is a clinical study titled "Effect of Sleep Extension on Ceramides in People with Overweight and Obesity". The overall goal is to determine how a sleep extension intervention (increasing time in bed) in individuals who maintain less than 6.5 hours sleep per night affects their plasma ceramides and insulin sensitivity. Participants will undergo a randomized controlled trial, with sleep extension (interven...

What is the current status of trial NCT06180837?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-02-12. Estimated completion is 2028-01.

What conditions does trial NCT06180837 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Sleep, Overweight and Obesity, Sleep Deprivation, Insulin Sensitivity.

What interventions are being tested in trial NCT06180837?

The interventions under investigation include: Sleep Extension Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06180837?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06180837 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.